ENTITY

AstraZeneca (AZN SS)

33
Analysis
Health Care • United Kingdom
AstraZeneca PLC is a Swedish-British multinational pharmaceutical and biotechnology company focused on the discovery, development, manufacture, and commercialization of prescription medicines. The company specializes in therapeutic areas including oncology, cardiovascular, renal and metabolism, respiratory and immunology, rare diseases, and vaccines. AstraZeneca was founded in 1999 through the merger of Sweden's Astra AB and the UK's Zeneca Group PLC, and its headquarters are located in Cambridge, UK.
more
•01 Oct 2021 00:00•Exchange-sponsored

SGX Asia Currencies and Commodities Insights

SGX Asia Currencies Insights Yuan stability should continue given risks from China’s rapidly slowing economy and ongoing financial stability...

Share
bullish•Pfizer
•12 Apr 2021 00:00•Exchange-sponsored

SGX Asia Currencies and Commodities Insights

By Macro Hive   SGX Asia Currencies Insights CNH has traded well against most currencies, and flows remain strong. Therefore, recent USD/CNH...

Share
bullish•AstraZeneca
•23 Feb 2021 22:39•Issuer-paid

Video: Oxford Biomedica – executive interview

Why are investors buying into Oxford Biomedica (LN:OXB)? In this interview, BBC broadcaster Vivienne Parry OBE asks CEO John Dawson why Oxford...

Share
x